Skip to main content
Top

07-05-2024 | Endoscopic Retrograde Cholangiopancreatography | Original Article

Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography

Authors: Briette Karanfilian, Amy Tyberg, Avik Sarkar, Haroon M. Shahid, Alexa Simon, Karoline Reinoso, Amol Bapaye, Ashish Gandhi, Harshal P. Gadhikar, Shivangi Dorwat, Hameed Raina, Jaseem Ansari, Jose Nieto, Nadim Qadir, Maria G. Porfilio, Martha Arevalo-Mora, Miguel Puga-Tejada, Juan Alcivar-Vasquez, Carlos Robles-Medranda, Jose Celso Ardengh, Romy Bareket, Kelvin Liao, Roohi Patel, Sophia Pimpinelli, Monica Gaidhane, Michel Kahaleh

Published in: Digestive Diseases and Sciences

Login to get access

Abstract

Background

Viral infections are known to impact the pancreato-biliary system; however, there are limited data showing that the same is true of COVID-19. Endoscopic retrograde cholangiopancreatography (ERCP) can safely be performed in patients with COVID-19 infection, but outcomes of patients with COVID-19 infections and concomitant pancreatic and biliary disease requiring endoscopic intervention are unknown.

Aims

This study aims to evaluate the severity of pancreaticobiliary diseases and post-ERCP outcomes in COVID-19 patients.

Methods

Patients with pancreato-biliary disease that required inpatient ERCP from five centers in the United States and South America between January 1, 2020, and October 31, 2020 were included. A representative cohort of patients from each month were randomly selected from each site. Disease severity and post-ERCP outcomes were compared between COVID-19 positive and COVID-19 negative patients.

Results

A total of 175 patients were included: 95 COVID positive and 80 COVID negative. Mean CTSI score for the patients who had pancreatitis was higher in COVID-positive cohort by 3.2 points (p < .00001). The COVID-positive group had more cases with severe disease (n = 41) versus the COVID-negative group (n = 2) (p < .00001). Mortality was higher in the COVID-19 positive group (19%) compared to COVID-negative group (7.5%) even though the COVID-19-negative group had higher incidence of malignancy (n = 17, 21% vs n = 7, 7.3%) (p = 0.0455).

Conclusions

This study shows that patients with COVID infection have more severe pancreato-biliary disease and worse post-ERCP outcomes, including longer length of stay and higher mortality rate. These are important considerations when planning for endoscopic intervention.
Clinicaltrials.gov: (NCT05051358).

Graphical Abstract

Literature
1.
go back to reference Kim KH, Kim SB. Comparison of the impact of endoscopic retrograde cholangiopancreatography between pre-COVID-19 and current COVID-19 outbreaks in South Korea: Retrospective survey. World J Clin Cases. 2021;9:8404–8412.CrossRefPubMedPubMedCentral Kim KH, Kim SB. Comparison of the impact of endoscopic retrograde cholangiopancreatography between pre-COVID-19 and current COVID-19 outbreaks in South Korea: Retrospective survey. World J Clin Cases. 2021;9:8404–8412.CrossRefPubMedPubMedCentral
2.
go back to reference Faruqui S, Okoli FC, Olsen SK, Feldman DM, Kalia HS, Park JS et al. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021;116:1414–1425.CrossRefPubMed Faruqui S, Okoli FC, Olsen SK, Feldman DM, Kalia HS, Park JS et al. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021;116:1414–1425.CrossRefPubMed
3.
go back to reference Wang Q, Zhao H, Liu LG, Wang YB, Zhang T, Li MH et al. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients. Mil Med Res. 2020;7:28.PubMedPubMedCentral Wang Q, Zhao H, Liu LG, Wang YB, Zhang T, Li MH et al. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients. Mil Med Res. 2020;7:28.PubMedPubMedCentral
4.
go back to reference Sharma A, Jaiswal P, Kerakhan Y, Saravanan L, Murtaza Z, Zergham A et al. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis. Ann Hepatol. 2021;21:100273.CrossRefPubMed Sharma A, Jaiswal P, Kerakhan Y, Saravanan L, Murtaza Z, Zergham A et al. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis. Ann Hepatol. 2021;21:100273.CrossRefPubMed
5.
6.
go back to reference Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D et al. Post-COVID-19 Cholangiopathy: A Novel Entity. Am J Gastroenterol. 2021;116:1077–1082.CrossRefPubMed Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D et al. Post-COVID-19 Cholangiopathy: A Novel Entity. Am J Gastroenterol. 2021;116:1077–1082.CrossRefPubMed
8.
go back to reference Tag-Adeen M, Yousef M, Osman H, Abdel-Gawad M, Elsayed M, Ozawa E, et al. Impact of COVID-19 pandemic on endoscopic retrograde cholangiopancreatography; a single center experience. Rev Esp Enferm Dig. 2021. Tag-Adeen M, Yousef M, Osman H, Abdel-Gawad M, Elsayed M, Ozawa E, et al. Impact of COVID-19 pandemic on endoscopic retrograde cholangiopancreatography; a single center experience. Rev Esp Enferm Dig. 2021.
9.
go back to reference An P, Huang X, Wan X, Xiao Y, Zhang J, Kang J et al. ERCP during the pandemic of COVID-19 in Wuhan. China. Gastrointest Endosc. 2020;92:448–454.CrossRefPubMed An P, Huang X, Wan X, Xiao Y, Zhang J, Kang J et al. ERCP during the pandemic of COVID-19 in Wuhan. China. Gastrointest Endosc. 2020;92:448–454.CrossRefPubMed
10.
go back to reference Salerno R, Conti CB, De Silvestri A, Campbell Davies SE, Mezzina N, Ardizzone S. The impact of covid-19 pandemic on urgent endoscopy in Italy: a nation-wide multicenter study. Scand J Gastroenterol. 2020;55:870–876.CrossRefPubMed Salerno R, Conti CB, De Silvestri A, Campbell Davies SE, Mezzina N, Ardizzone S. The impact of covid-19 pandemic on urgent endoscopy in Italy: a nation-wide multicenter study. Scand J Gastroenterol. 2020;55:870–876.CrossRefPubMed
12.
go back to reference Leeds JS, Awadelkarim B, Dipper C, Nayar MK, Oppong KW, Nylander DL. Effect of the SARS-CoV2 Pandemic on Endoscopy Provision - The Impact of Compliance with National Guidance. Expert Rev Gastroenterol Hepatol. 2021;15:459–464.CrossRefPubMed Leeds JS, Awadelkarim B, Dipper C, Nayar MK, Oppong KW, Nylander DL. Effect of the SARS-CoV2 Pandemic on Endoscopy Provision - The Impact of Compliance with National Guidance. Expert Rev Gastroenterol Hepatol. 2021;15:459–464.CrossRefPubMed
14.
go back to reference Leow VM, Mohamad IS, Subramaniam M. Use of aerosol protective barrier in a patient with impending cholangitis and unknown COVID-19 status undergoing emergency ERCP during COVID-19 pandemic. BMJ Case Rep. 2020;13. Leow VM, Mohamad IS, Subramaniam M. Use of aerosol protective barrier in a patient with impending cholangitis and unknown COVID-19 status undergoing emergency ERCP during COVID-19 pandemic. BMJ Case Rep. 2020;13.
15.
go back to reference Ljubicic N, Stojsavljevic-Shapeski S, Virovic-Jukic L, Nikolic M. Plexiglas barrier box to improve ERCP safety during the COVID-19 pandemic. Gastrointest Endosc. 2020;92:428–429.CrossRefPubMedPubMedCentral Ljubicic N, Stojsavljevic-Shapeski S, Virovic-Jukic L, Nikolic M. Plexiglas barrier box to improve ERCP safety during the COVID-19 pandemic. Gastrointest Endosc. 2020;92:428–429.CrossRefPubMedPubMedCentral
17.
go back to reference Voiosu T, Voiosu A, Boskoski I, Arvanitakis M, Bronswijk M, Hollenbach M et al. Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19. Therap Adv Gastroenterol. 2020;13:1756284820980671.CrossRefPubMedPubMedCentral Voiosu T, Voiosu A, Boskoski I, Arvanitakis M, Bronswijk M, Hollenbach M et al. Technical and clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in patients with COVID-19. Therap Adv Gastroenterol. 2020;13:1756284820980671.CrossRefPubMedPubMedCentral
Metadata
Title
Impact of COVID-19 Infection on Pancreato-Biliary Diseases Requiring Endoscopic Retrograde Cholangiopancreatography
Authors
Briette Karanfilian
Amy Tyberg
Avik Sarkar
Haroon M. Shahid
Alexa Simon
Karoline Reinoso
Amol Bapaye
Ashish Gandhi
Harshal P. Gadhikar
Shivangi Dorwat
Hameed Raina
Jaseem Ansari
Jose Nieto
Nadim Qadir
Maria G. Porfilio
Martha Arevalo-Mora
Miguel Puga-Tejada
Juan Alcivar-Vasquez
Carlos Robles-Medranda
Jose Celso Ardengh
Romy Bareket
Kelvin Liao
Roohi Patel
Sophia Pimpinelli
Monica Gaidhane
Michel Kahaleh
Publication date
07-05-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08454-1
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.